Online inquiry

IVTScrip™ mRNA-Human ADGRD1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK8934MR)

This product GTTS-WK8934MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADGRD1 protein. This product can be used in FGFR1 High NME5-epithelial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001330497.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 283383
UniProt ID Q6QNK2
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADGRD1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK8934MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK20303MR IVTScrip™ mRNA-Human ANKRD17, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ANKRD17
GTTS-WK23511MR IVTScrip™ mRNA-Human ARHGEF18, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGEF18
GTTS-WK9076MR IVTScrip™ mRNA-Human ABI3BP, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ABI3BP
GTTS-WK19569MR IVTScrip™ mRNA-Human AKIRIN1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AKIRIN1
GTTS-WK19056MR IVTScrip™ mRNA-Human AMOTL1, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA AMOTL1
GTTS-WK2343MR IVTScrip™ mRNA-Human CD133, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA CD133
GTTS-WK23540MR IVTScrip™ mRNA-Human ARL3, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ARL3
GTTS-WK21510MR IVTScrip™ mRNA-Human ANKRD20A9P, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD20A9P
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW